Wave Life Sciences Ltd. Ordinary Shares (WVE) Dividend History

Wave Life Sciences Ltd. is a biotechnology company focused on the development of precision medicine therapies for genetic diseases. Founded with the goal of leveraging nucleic acid technologies, the company specializes in designing and developing synthetic oligonucleotide therapies to target specific genetic mutations, primarily in areas such as rare neurodegenerative and neuromuscular diseases. Headquartered in the United States, Wave Life Sciences aims to bring innovative treatments to patients with unmet medical needs through its proprietary platform.

7 Straits View, Singapore, U0, 018936
Phone: 617-949-2900
Website: https://www.wavelifesciences.com

Dividend History

Wave Life Sciences Ltd. Ordinary Shares currently does not pay dividends

Company News

Elkedonia clôture un tour d’amorçage de 11 millions d’euros pour le développement de neuroplastogènes comme traitements novateurs contre la dépression et les troubles neuropsychiatriques

Elkedonia, a French-Belgian startup, has raised €11.25 million in seed funding to develop novel, fast-acting, non-addictive, and non-hallucinogenic treatments for treatment-resistant depression and other neuropsychiatric disorders. The company's approach targets the intracellular protein Elk1, which plays a key role in brain reward circuits and neuroplasticity.

GlobeNewswire Inc.
1 Brand-New Big Reason to Buy This Biotech Stock Right Now

Wave Life Sciences, a biotech company, has reached a significant milestone in its clinical trial for a treatment for alpha-1 antitrypsin deficiency (AATD). While the results are promising, the company still faces significant risks, including the need to raise additional capital and the potential for clinical trial failures.

The Motley Fool
Oklo, CleanSpark And Wolfspeed Are Among Top 7 Mid Cap Gainers Last Week (Oct 14-18): Are The Others In Your Portfolio?

Several mid-cap stocks, including Oklo, CleanSpark, and Wolfspeed, saw significant gains last week. The article highlights the reasons behind the stock movements and encourages readers to check if these companies are in their portfolios.

Benzinga

Featured Companies: CLSK IONQ OKLO TDS WOLF
NeoGenomics (NEO) Reports Q1 Loss, Tops Revenue Estimates

NeoGenomics (NEO) delivered earnings and revenue surprises of 33.33% and 4.29%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research

Featured Companies: NEO
Penny Stocks To Buy Now? 4 To Watch Before 2024

Are these penny stocks a buy before next year? The post Penny Stocks To Buy Now? 4 To Watch Before 2024 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

PennyStocks

Featured Companies: DCTH NKTX TOI

Page data last updated 07/22/2025 15:33:40 UTC